vs
Astrana Health, Inc.(ASTH)与RANGE RESOURCES CORP(RRC)财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是RANGE RESOURCES CORP的1.2倍($950.5M vs $786.9M),RANGE RESOURCES CORP净利率更高(22.8% vs 0.7%,领先22.1%),Astrana Health, Inc.同比增速更快(42.9% vs 18.0%),过去两年Astrana Health, Inc.的营收复合增速更高(53.3% vs 14.6%)
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业,核心运营区域为马塞勒斯页岩地层,是该地区拥有土地面积最大的运营商,专注于天然气资源的勘探、开发与生产业务,在北美油气开发领域具备深厚的行业积累。
ASTH vs RRC — 直观对比
营收规模更大
ASTH
是对方的1.2倍
$786.9M
营收增速更快
ASTH
高出24.9%
18.0%
净利率更高
RRC
高出22.1%
0.7%
两年增速更快
ASTH
近两年复合增速
14.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $950.5M | $786.9M |
| 净利润 | $6.6M | $179.1M |
| 毛利率 | — | 94.5% |
| 营业利润率 | 1.9% | — |
| 净利率 | 0.7% | 22.8% |
| 营收同比 | 42.9% | 18.0% |
| 净利润同比 | 184.4% | 88.8% |
| 每股收益(稀释后) | $0.12 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASTH
RRC
| Q4 25 | $950.5M | $786.9M | ||
| Q3 25 | $956.0M | $655.3M | ||
| Q2 25 | $654.8M | $699.6M | ||
| Q1 25 | $620.4M | $846.3M | ||
| Q4 24 | $665.2M | $667.0M | ||
| Q3 24 | $478.7M | $567.9M | ||
| Q2 24 | $486.3M | $513.2M | ||
| Q1 24 | $404.4M | $598.8M |
净利润
ASTH
RRC
| Q4 25 | $6.6M | $179.1M | ||
| Q3 25 | $373.0K | $144.3M | ||
| Q2 25 | $9.4M | $237.6M | ||
| Q1 25 | $6.7M | $97.1M | ||
| Q4 24 | $-7.8M | $94.8M | ||
| Q3 24 | $16.1M | $50.7M | ||
| Q2 24 | $19.2M | $28.7M | ||
| Q1 24 | $14.8M | $92.1M |
毛利率
ASTH
RRC
| Q4 25 | — | 94.5% | ||
| Q3 25 | — | 92.5% | ||
| Q2 25 | — | 95.0% | ||
| Q1 25 | — | 93.1% | ||
| Q4 24 | — | 93.7% | ||
| Q3 24 | — | 94.3% | ||
| Q2 24 | — | 93.4% | ||
| Q1 24 | — | 94.7% |
营业利润率
ASTH
RRC
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | 7.5% | — |
净利率
ASTH
RRC
| Q4 25 | 0.7% | 22.8% | ||
| Q3 25 | 0.0% | 22.0% | ||
| Q2 25 | 1.4% | 34.0% | ||
| Q1 25 | 1.1% | 11.5% | ||
| Q4 24 | -1.2% | 14.2% | ||
| Q3 24 | 3.4% | 8.9% | ||
| Q2 24 | 3.9% | 5.6% | ||
| Q1 24 | 3.7% | 15.4% |
每股收益(稀释后)
ASTH
RRC
| Q4 25 | $0.12 | $0.75 | ||
| Q3 25 | $0.01 | $0.60 | ||
| Q2 25 | $0.19 | $0.99 | ||
| Q1 25 | $0.14 | $0.40 | ||
| Q4 24 | $-0.14 | $0.38 | ||
| Q3 24 | $0.33 | $0.21 | ||
| Q2 24 | $0.40 | $0.12 | ||
| Q1 24 | $0.31 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $204.0K |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | $779.3M | $4.3B |
| 总资产 | $2.2B | $7.4B |
| 负债/权益比越低杠杆越低 | — | 0.28× |
8季度趋势,按日历期对齐
现金及短期投资
ASTH
RRC
| Q4 25 | $429.5M | $204.0K | ||
| Q3 25 | $463.4M | $175.0K | ||
| Q2 25 | $342.1M | $134.0K | ||
| Q1 25 | $260.9M | $344.6M | ||
| Q4 24 | $290.8M | $304.5M | ||
| Q3 24 | $350.3M | $277.4M | ||
| Q2 24 | $327.7M | $251.1M | ||
| Q1 24 | $337.3M | $343.1M |
总债务
ASTH
RRC
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
股东权益
ASTH
RRC
| Q4 25 | $779.3M | $4.3B | ||
| Q3 25 | $775.5M | $4.2B | ||
| Q2 25 | $765.5M | $4.1B | ||
| Q1 25 | $745.4M | $3.9B | ||
| Q4 24 | $712.7M | $3.9B | ||
| Q3 24 | $704.6M | $3.9B | ||
| Q2 24 | $678.9M | $3.9B | ||
| Q1 24 | $653.5M | $3.8B |
总资产
ASTH
RRC
| Q4 25 | $2.2B | $7.4B | ||
| Q3 25 | $2.2B | $7.2B | ||
| Q2 25 | $1.4B | $7.1B | ||
| Q1 25 | $1.3B | $7.4B | ||
| Q4 24 | $1.4B | $7.3B | ||
| Q3 24 | $1.3B | $7.2B | ||
| Q2 24 | $1.3B | $7.3B | ||
| Q1 24 | $1.2B | $7.4B |
负债/权益比
ASTH
RRC
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | 1.44× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势,按日历期对齐
经营现金流
ASTH
RRC
| Q4 25 | $-2.9M | $257.5M | ||
| Q3 25 | $10.0M | $247.5M | ||
| Q2 25 | $90.9M | $336.2M | ||
| Q1 25 | $16.6M | $330.1M | ||
| Q4 24 | $-10.9M | $217.9M | ||
| Q3 24 | $34.0M | $245.9M | ||
| Q2 24 | $23.2M | $148.8M | ||
| Q1 24 | $6.0M | $331.9M |
自由现金流
ASTH
RRC
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
自由现金流率
ASTH
RRC
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
资本支出强度
ASTH
RRC
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
现金转化率
ASTH
RRC
| Q4 25 | -0.44× | 1.44× | ||
| Q3 25 | 26.69× | 1.72× | ||
| Q2 25 | 9.65× | 1.42× | ||
| Q1 25 | 2.48× | 3.40× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | 2.11× | 4.85× | ||
| Q2 24 | 1.21× | 5.18× | ||
| Q1 24 | 0.40× | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |